Comparison of Conventional Fractionation and Accelerated Fractionation With Concomitant Boost for Radiotherapy of Non-metastatic Stage IV Head-and-Neck Cancer

Conclusion: Accelerated fractionation with concomitant boost appeared superior to conventional fractionation and can be considered for patients with stage IV SCCHN not suitable for radiochemotherapy. Larger studies are needed to confirm these findings.

Source: In Vivo - January 5, 2021 Category: Research Authors: NARVAEZ, C., SCHILD, S. E., RADES, D. Tags: Clinical Studies Source Type: research